Cargando…
Severe thrombocytopenia after Vaxzevria vaccination in a single patient: A case report
AstraZeneca vaccine became one of the four vaccines that encode different forms of the SARS-CoV-2 spike glycoprotein. We report the case of an 18-year-old medically free female with progressive bruising of the upper and lower extremities for 1 week, beginning 3 days after the first dose of AstraZene...
Autores principales: | Al-Ansari, Rehab Y, AL Qahtany, Faisal Hani, Qomawi, Yasmin, Fadoul, Tawasoul, Woodman, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019373/ https://www.ncbi.nlm.nih.gov/pubmed/35465020 http://dx.doi.org/10.1177/2050313X221091407 |
Ejemplares similares
-
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia
por: Gordon, Sally F., et al.
Publicado: (2021) -
Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia
por: Al-Ansari, Rehab Y., et al.
Publicado: (2022) -
Subacute Thyroiditis After Severe Acute Respiratory Syndrome Coronavirus 2 Vaxzevria Vaccination in a Patient With Thyroid Autoimmunity
por: Borges Canha, Marta, et al.
Publicado: (2022) -
Serum negative neuromyelitis optica spectrum disorder after vaxzevria vaccination: A case report
por: Gorgone, Gaetano, et al.
Publicado: (2021) -
Can a supranational medicines agency restore trust after vaccine suspensions? The case of Vaxzevria
por: Albanese, Andrea, et al.
Publicado: (2022)